<DOC>
	<DOC>NCT01113047</DOC>
	<brief_summary>This study will assess the efficacy and safety of the single pill combination of Aliskiren and Amlodipine in patients with moderate hypertension not adequately responding to a single pill combination of Olmesartan and Amlodipine. Further this study will also assess the efficacy and safety of a single pill combination of Aliskiren, Amlodipine and Hydrochlorothiazide (HCTZ) in patients with moderate hypertension not adequately responding to a single pill combination of Aliskiren and Amlodipine.</brief_summary>
	<brief_title>Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Essential hypertension stage II Male and female patients Age &gt;= 18 years old Severe hypertension (systolic BP &gt;= 180 mmHg, diastolic BP &gt;= 110 mmHg Poorly controlled diabetes mellitus or type 1 DM History of myocardial infarction, stroke Presence of heart failure Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Aliskiren</keyword>
	<keyword>Amlodipine</keyword>
</DOC>